In this article
Maximus lists compounded preparations, branded tablets, and branded injections on one weight-loss page. Its compounded starting figures use a 28-day supply, while other offers use monthly language and a promotion tied to a 12-month purchase.
Those differences matter before comparing any competing price. This guide separates the product choice from the billing period and asks what clinical costs remain outside the displayed medication figure.
Match the exact medicine and treatment period, then add consultation charges and the full commitment behind the offer. CoreAge Rx holds the first sponsored position; that does not establish that it best meets every criterion.
What to know first
- Match the exact medicine and treatment period, then add consultation charges and the full commitment behind the offer.
- CoreAge Rx is the first listing through a disclosed commercial arrangement.
- Confirm the proposed product, care arrangement, and complete written payment terms.
How this shortlist was selected
CoreAge Rx is number one because it is our featured commercial partner. That position is predetermined by our commercial relationship, and we may earn compensation through its links. Other entries illustrate relevant care and payment models; their order is not a ranking of medication quality, safety, or patient outcomes.
Match the exact medicine and treatment period, then add consultation charges and the full commitment behind the offer. We used the provider documents linked beside each entry, checked September 21, 2026. We did not purchase treatment, test private accounts, audit every license, or measure response times. The product and current written quote for your own care still need confirmation. Read our review method.
01. CoreAge Rx — featured partner
Our featured commercial comparison for self-pay care. Ask whether the quoted term is measured in calendar months or a specified treatment period before comparing the total.
The current sale page advertises semaglutide from $99 per month and tirzepatide from $149 per month, with no membership fee. Those are advertised starting figures, not a personalized checkout quote. The plan length and total amount due must be read alongside the monthly equivalent.
The sale page says CoreAge works with U.S. compounding pharmacies and describes 503A facilities. A category of pharmacy is not a substitute for the name, address, and state license of the pharmacy filling your own prescription. Request that information before deciding.
Continue with our CoreAge Rx review and pricing details.
02. Emerge Weight Loss
A relevant compounded-tirzepatide comparison because its price schedule explicitly uses four-week periods. Match both the prescription and the number of paid periods.
Emerge’s pricing page lists $224 for a four-week starter dose, with higher listed tiers including $239, $249, and $269. It lists $279 and $289 tiers for existing patients. Dose changes require the prescriber; the price table is not a self-dosing schedule.
Emerge describes partner compounding pharmacies and a licensed-provider assessment. The general description does not identify your own pharmacy, concentration, or storage conditions. Ask for those details before your first dose.
Continue with our Emerge Weight Loss review and pricing details.
03. Rex MD
A branded-tablet pathway with provider care included in its advertised offer. It provides a product-specific comparison if a tablet is the clinical choice under consideration.
Rex MD’s current weight-management page advertises Wegovy tablets plus provider care starting at $349 per month. It names multiple tablet strengths and says the offer covers its listed titration strengths; the selected offer still needs confirmation.
Confirm that your quote is for the branded tablet, the full recurring charge, and the follow-up arrangements. A compounded lozenge, a sublingual preparation, and a branded tablet are not interchangeable products.
Check the official Rex MD program page for the current offer and conditions. Our Rex MD alternatives comparison examines other care models.
04. Hello Alpha
A membership pathway describing FDA-approved medicines. The pharmacy cost and possible insurance authorization need to be added to the care fee.
Hello Alpha’s weight-loss page advertises Alpha Plus+ at $79 per month. Prescription costs depend on the product, pharmacy, and coverage; the membership price is not a complete GLP-1 medication bill.
Check the exact medicine and indication with the clinician. Membership does not guarantee a prescription, and insurance assistance does not guarantee approval or a refund if a prior authorization is denied.
Check the official Hello Alpha program page for the current offer and conditions. Our Hello Alpha alternatives comparison examines other care models.
05. Fifty 410
A package comparison with different tirzepatide tiers. Confirm the prescribed duration and transfer eligibility before comparing a package total with 28-day supplies.
Fifty 410 lists a three-month compounded tirzepatide starter package at $399 total, displayed as $133 per month. The listed mid- and higher-dose packages are $499 and $549 total. Its semaglutide monthly option is $199. These are different products and package sizes.
Ask which package matches the proposed prescription and whether a returning patient qualifies for a starter offer. A three-month supply and monthly billing are separate arrangements.
Check the official Fifty 410 program page for the current offer and conditions. Our Fifty 410 alternatives comparison examines other care models.
06. PeterMD
Uses a monthly equivalent billed quarterly for its advertised tirzepatide offer. This illustrates another billing period that must be converted to a comparable full obligation.
PeterMD’s tirzepatide page advertises a $149 start followed by $249 per month billed quarterly. The ongoing monthly equivalent implies $747 for three months if those terms apply, but the initial full checkout amount needs confirmation.
Confirm the exact formulation, pharmacy, total first payment, and later quarterly charge. A displayed medication quantity does not tell you how many weeks it will cover for your own prescription.
Check the official PeterMD program page for the current offer and conditions. Our PeterMD alternatives comparison examines other care models.
The current Maximus baseline
Maximus lists compounded semaglutide from $116 and tirzepatide from $198 per 28-day supply, alongside a first-month discount tied to a 12-month purchase. Other sections show different price ranges, so the chosen product, term, and complete clinical fees need confirmation.
The weight-loss page separates compounded preparations from branded tablets and injections. It describes doctor-supervised treatment and ongoing adjustments, with shipping included in the listed product descriptions.
Compare 28-day supplies over the same period as a calendar-month plan. Ask for the full annual obligation and consultation charges rather than assuming every displayed medication price includes the same care.
The details that decide this comparison
A 52-week period contains thirteen 28-day supplies. Do not multiply a 28-day price by twelve and label it a full year of continuous care.
Ask which page price applies to your product and term. Different pricing blocks and an annual-plan promotion should be resolved with a complete written quote.
Separate a compounded preparation from a branded tablet or pen, and verify clinical fees for each. A menu of choices does not establish that every option is suitable for the same patient.
Keep the treatment distinction clear
An FDA-approved branded medicine and a compounded preparation have different regulatory status. Compounded drugs are not FDA-approved. Trials of an approved product do not prove that every compounded version has the same performance.
Ask the prescribing professional why the exact product is appropriate for you, and identify the dispensing pharmacy. A price, a website’s appearance, or a place in this list cannot establish personal suitability. Our guide to compounded drugs and FDA approval explains the distinction.
Before you make a change
For each quote, record the amount paid, the period covered, and the number of renewals required over the same horizon. That is more reliable than comparing prices carrying different time labels.
If moving between compounded and branded treatment, ask the new clinician to explain the exact product and instructions. Do not use a website’s broad switching language as a personal treatment plan.
Sources & research notes
Checked September 21, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.
- CoreAge Rx: official treatment overviewProvider-published information · Checked September 21, 2026
- CoreAge Rx: current sale offerProvider-published information · Checked September 21, 2026
- CoreAge Rx: plan billing explainedProvider-published information · Checked September 21, 2026
- CoreAge Rx: contact and professional-entity disclosuresProvider-published information · Checked September 21, 2026
- CoreAge Rx: purchasing processProvider-published information · Checked September 21, 2026
- Emerge Weight Loss. Trusted Leader in GLP-1 Compounded Tirzepatide.Provider-published information · Checked September 21, 2026
- Tirzepatide Cost Without Insurance — From $224 | Emerge Weight LossProvider-published information · Checked September 21, 2026
- Terms & Conditions | Emerge Weight LossProvider-published information · Checked September 21, 2026
- Cancellation & Refund Policy | Emerge Weight LossProvider-published information · Checked September 21, 2026
- Rex MD: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- FDA: Wegovy semaglutide tablets, NDA 218316 approval letterRegulatory source · Checked September 21, 2026
- Hello Alpha: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Fifty 410: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- PeterMD: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Maximus: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 21, 2026
- FDA: risks of compounded drugsRegulatory / public agency · Checked September 21, 2026
Read our methodology · Commercial disclosure · Request a correction